Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Rivastigmine Study in Adolescents With Down Syndrome (DS-Riv)

This study has been completed.
Taishoff Family Foundation
Information provided by (Responsible Party):
Duke University Identifier:
First received: March 8, 2010
Last updated: November 25, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)